K252681: EnCor EnCompass™ Breast Biopsy and Tissue Removal System (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K252681 (EnCor EnCompass™ Breast Biopsy and Tissue Removal System, cleared 2025-12-12 for Bard Peripheral Vascular, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K252681 |
| Cleared Device Trade / Generic Name | EnCor EnCompass™ Breast Biopsy and Tissue Removal System |
| FDA Applicant on Filing | Bard Peripheral Vascular, Inc. |
| FDA 3-Letter Product Classification | Product Code KNW |
| FDA Substantial Equivalence Decision Date | 2025-12-12 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at Bard Peripheral Vascular, Inc., compare peer devices under FDA Product Code KNW, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.